GliaPharm has established a proprietary drug discovery platform, GliaX™, centered on glial cells activity and brain metabolism.
Through this platform, the company is developing its pipeline program to establish a new class of agents for neuroprotection and maintenance of cognitive functions.
GliaX™ also serves collaboration with academic and industrial partners.